[224 Pages Report] The global Endoscopy Visualization Systems Market is estimated to expand from a value of US$ 1.3 Bn in 2021, to a value of US$ 2.2 Bn by 2028 end, and growing at a CAGR of 7.2% during the forecast period.
Increase in number of endoscopic surgeries performed globally each year is a major factor accounted for growth of endoscopy imaging market. The global healthcare industry is witnessing an increase in the number of endoscopic surgeries performed each year, rising focus on minimally invasive endoscopic surgeries and other macroeconomic factors, such as increase in per capita health care expenditure. All these factors driving the growth of the endoscopy visualization systems market.
High incidence of gynecology, gastrointestinal diseases, urology, and lung disorders presents a huge patient pool who do endoscopic surgeries each year, specifically in developing countries. These aspects can propel the growth of the endoscopy visualization components market.
With the help of modernization act (MMA), manufacturers and developers need to submit premarket submissions and get FDA approval before getting their product in the market. This reduces the time for regulatory agreement – reducing costs significantly and propelling the growth of the endoscopy visualization system markets over a long run.
Endoscopy visualization system provides magnified and high-definition endoscopic images and makes it easier for visualization and precise classification of flat and small polyp’s lesions. This technology makes the treatment easy, as well as help in healthcare savings and propel endoscope reprocessing devices.
Acquisitions, mergers, expansion, product launches and agreements are the key strategies adopted by manufacturers to increase the product sales in different geographies. The companies in the market are focusing on introduction of new products to strengthen product portfolio.
Endoscopy visualization systems market Outlook:
Data Points | Market Insights |
---|---|
Market Value 2022 | USD 1.4 Billion |
Forecasted Global Market Value (2028) | USD 2.2 Billion |
Market Growth Rate 2022 to 2028 | 7.2% |
Top 3 Countries % Share | 44.9% |
Key Players | Olympus Corporation; Pentax Medical Company (Hoya Corporation); Fujifilm Holding Corporation; Karl Storz GmbH & Co KG; Richard Wolf GmbH and Boston Scientific Corporation are the key players in endoscopy visualization systems market. They take about 73% share. |
Don't pay for what you don't need
Customize your report by selecting specific countries or regions and save 30%!
Particulars | Details |
---|---|
H1, 2021 | 7.28% |
H1, 2022 Projected | 7.19% |
H1, 2022 Outlook | 7.09% |
BPS Change - H1, 2022 (O) - H1, 2022 (P) | (-) 10 ↓ |
BPS Change – H1, 2022 (O) - H1, 2021 | (-) 19 ↓ |
According to Future Market Insights Analysis, the global endoscopy visualization systems market observed a diminished change in the Basis Point Share (BPS) by nearly 19 BPS in H1- 2022(O) compared to H1-2021, whereas, in comparison to H1-2022 Projected value, the market growth rate during H1-2022 outlook period will show a dip of 10 BPS.
This was majorly due to the impact of the COVID-19 pandemic which affected the overall market scenario by postponement of elective surgical procedures, thereby negatively affecting the endoscopic visualization systems market. This is based on value consumption as per the company’s reported revenue.
In developing markets like India, the cost of these visualization systems are very high and this contributes to less growth of the endoscopy visualization in this country. Additionally, the cost recovery scenario in developing regions is quite low which will result in slower growth of this market.
Despite these negative aspects, increasing healthcare expenditure in developed regions, along with technological advances in in-vivo imaging systems will fuel the growth of endoscopy visualization market.
Sales of endoscopy visualization systems market grew at a CAGR of 6.0% between 2013 and 2021.
In 2020, the global market of endoscopy visualization systems accounts for approx. 10.1% of the overall endoscopy market that accounts around US$ 13.2 Bn.
Rising demand for minimally invasive procedures will have a high impact on endoscopy visualization system market. Traditionally done surgeries are complex procedures, however, minimally invasive procedures are less complex and safe as they involve smaller incisions on the patient’s body. This procedures is highly adapted by patient due to its less invasive nature and also lesser time taken during surgery plus quick recovery post-surgery. Hence, the demand for endoscopy visualization systems has risen in the recent times.
Minimally invasive procedures have various advantage like less blood loss & reduced chances of infection, rapid recovery time and less marks after surgery on the body. These benefits have attracted a lot of end user consideration thus, driving the endoscopy visualization system market.
Considering this, it is expected for the global endoscopy visualization systems market to grow at a CAGR of 7.2% through 2028.
A country-level lockdown impacted the endoscopy visualization systems market negatively. The pandemic resulted in a global decline in medical device demand. The market for endoscopy visualization systems was also hampered due to the cancellation or postponement of elective and non-urgent endoscopic treatments.
Furthermore, strict endoscopy facilities regulations led to reduced surgical volume even more. Because of the government's stringent measures, manufacturers, sellers, and distributors in the market continued to be impacted by the pandemic. Aside from that, a number of government-run cancer screening programs and projects have been suspended or cancelled. However, the use of single-use disposable endoscopes saw a tremendous rise during the same time period which enabled improved infection management.
High costs for endoscopy visualization system is expected to hamper the growth of market over the forecast period. Installations, repair, service of equipment of endoscope involves high cost. Partial financial support from government in installation also adds to the restraining factor for the growth of the global endoscopy visualization system market
Prospect of installation price return depends on the number of procedures performed per day and availability of good medical facilities. Hence, cost recovering is quite uncertain in regions where medical facilities and surgical procedures are limited and therefore, involves high risk. This factor may restrain the market growth at high rate.
Moreover, lack of trained endoscopy specialists and professionals also adds to the constraints for the growth of endoscopy visualization systems market.
The U.S. is estimated to account for over 84.9% of the North America endoscopy visualization systems market in 2022. High adoption of technologically advanced systems and devices by the medical facilities and huge number of medical institutions are expected to drive the demand in this country.
Increasing healthcare expenditure by governments has enabled the installation and usage of sophisticated endoscopy visualization systems for endoscopic surgeries in hospitals of U.S. which will fuel the overall revenue of the endoscopy visualization systems and drive the growth of the market.
Moreover, focus on new technology development with advancements in medical device industry exhibiting innovative product design and enhanced patient safety is expected to create a huge platform for innovative technologies in U.S
Germany is estimated to account for 27.0% market revenue share in Europe in 2022. Rising geriatric population, increased obesity rates, growing incidence of associated disease, rising awareness among the patient population and well established healthcare facilities are the major factor boosting the demand for endoscopy visualization systems market in Germany.
For instance, According to the World Health Aging 2020 highlights by the United Nations Department of Economic and Social Affairs, in October 2020, the number of people aged 65 years and older was estimated to be around 727 million globally. In 2020, population aged 65 years and above for Germany was 21.7 %. Population ages 65 and above as a percentage of the total population.
China having great growth opportunities due to changing demographics in emerging economies and growth is demonstrated with CAGR 8.7% by 2028.
Additionally, rapid technological advancement, increasing case of chronic diseases and the increase in disposable income within this particular region is boosting the demand for endoscopy visualization systems.
Emerging economies such as china and japan are expected to provide high growth opportunities for endoscopy visualization market. Healthcare expenditure for public and private use in these countries is projected to see huge growth, which in turn is expected to drive the focus of the manufacturers in these markets.
According to the World Bank Group in 2014 China’s healthcare expenditure was 5.5% of the GDP, and increased in 2020
Recently demand for endoscopy visualization systems market in India is rising and contribute 19.5% market share by value in 2021.
Developing countries such as India have a large share of undiagnosed patients. These geographies represent a big opportunity for medical device manufacturers.
Additionally, the increasing demand for endoscopic procedures due to high prevalence of urology, cancer, gynecology, gastrointestinal, and other cavity disorders owing to changing lifestyle is expected to drive the demand for endoscopy visualization systems in the India.
High Range EVS accounts for the highest share of around 47.9% in 2021 due to advanced clear image producing technology at less cost and high specificity as compared with low and medium range system.
High-Range EVS is gaining traction due to high adoption of this procedures in endoscopy visualization system as they provide more clear image with advanced features as compared to low and mid-range EVS.
By disease Type, gastrointestinal tract is the leading segments and hold around 21.4% market revenue share in 2021.
There’s a high prevalence of gastrointestinal infectious diseases all over the world due to unhealthy lifestyles and malnutrition. Pain of such diseases is unbearable and physician preference for endoscopy to diagnose the related issues better and provide for effective treatment options. Hence, this segments is highest revenue generating segment.
According to reported data from the Center for Science in the Public Interest, in 2020, unhealthy diets contributed to approximately 678,000 deaths each year in the U.S.
By end user, hospitals segment lead the market with market share of 67.4% in 2021 owing to an increase in the use of endoscopic equipment in hospitals, rising government and private support in the healthcare industry, and increasing number of skilled healthcare professionals and technologically advanced services in medical institutions.
Additionally, most of patient prefer to go to hospital for diagnosis. As the treatment and diagnosis is easily available in hospital. Endoscopy visualization systems can be easily installed in hospitals and more walk in patient can by entertained for treatment. Thus this segment will witness significant growth in recent years.
Get the data you need at a Fraction of the cost
Personalize your report by choosing insights you need
and save 40%!
The endoscopy visualization systems market is an extremely consolidated market, with major competitors such as Olympus Corporation, Pentax Medical Company (Hoya Corporation), Fujifilm Holding Corporation, Karl Storz GmbH & Co KG, Richard Wolf GmbH and Boston Scientific Corporation, Smith & Nephew, ConMed Corporation, Stryker Corporation, Terumo Corporation, DePuy Synthes (Johnson & Johnson Services, Inc. ) operating in every region of the globe. To attract more customers, major players are focusing on mergers and acquisition and launching novel products in order to boost their market position and expand their product portfolios.
Attribute | Details |
---|---|
Forecast Period | 2022 to 2028 |
Historical Data Available for | 2013 to 2021 |
Market Analysis | USD Million for Value and Volume in Unit |
Key Countries Covered | USA, Canada, Brazil, Mexico, Argentina, Germany, UK, France, Spain, Russia, China, Japan, South Korea, India, Australia, New Zealand, GCC Countries, South Africa |
Key Segments Covered | Product Type, Area End User and Region |
Key Companies Profiled | Olympus Corporation; Pentax Medical Company (Hoya Corporation); Fujifilm Holding Corporation; Karl Storz GmbH & Co KG; Richard Wolf GmbH; Boston Scientific Corporation; Smith & Nephew; ConMed Corporation; Stryker Corporation; Terumo Corporation; DePuy Synthes (Johnson & Johnson Services, Inc.) |
Report Coverage | Market Forecast, Competition Intelligence, DROT Analysis, Market Dynamics and Challenges, Strategic Growth Initiatives |
Customization & Pricing | Available upon Request |
By Product Type
By Area
By End User
By Region
The global endoscopy visualization systems market is worth US$ 1.3 Bn in 2021 and is set to expand with CAGR of 7.2% over forecast period.
The market is expected to reach US$ 2.2 Bn by the end of 2028.
The sales of endoscopy visualization systems market have grown at a CAGR of nearly 6.0% between 2013 and 2021.
Gastrointestinal Tract have huge growth opportunities for endoscopy visualization systems market and is expected to grow at a CAGR of nearly 8.0% between 2022 and 2028.
US, Japan, China are the top 3 countries that are driving the demand.
1. Executive Summary
1.1. Market Overview
1.2. Market Analysis
1.3. FMI Analysis and Recommendations
1.4. Wheel of Fortune
2. Market Introduction
2.1. Market Taxonomy
2.2. Market Definition
3. Endoscopy Visualization Systems Market Opportunity Analysis
3.1. Macro-Economic Factors
3.2. Opportunity Assessment
4. Market Background
4.1. Recent Developments
4.2. Market Dynamics
4.2.1. Drivers
4.2.2. Restraints
4.2.3. Trends
5. Global Economic Outlook
5.1. Gross Domestic Product by Region & Country, 2013 – 2021
6. Key Inclusions
6.1. Key Regulations
6.2. Reimbursement Scenario
6.3. Pricing Analysis
7. North America Endoscopy Visualization Systems Market Analysis 2013–2021 and Forecast 2022–2028
7.1. Introduction
7.2. Regional Market Trends
7.3. Historical Market Size (US$ Mn) Analysis By Country, 2013–2021
7.3.1. U.S.
7.3.2. Canada
7.4. Market Size (US$ Mn) Forecast By Country, 2022–2028
7.5. Historical Market Size (US$ Mn) Trend Analysis By Product Type, 2013–2021
7.5.1. High-Range Endoscopy Visualization Systems
7.5.2. Mid-Range Endoscopy Visualization Systems
7.5.3. Low-Range Endoscopy Visualization Systems
7.6. Market Size (US$ Mn) Forecast By Product Type, 2022–2028
7.7. Historical Market Size (US$ Mn) Trend Analysis By Areas Type, 2013–2021
7.7.1. Gastrointestinal tract
7.7.2. Respiratory tract
7.7.3. Ear
7.7.4. Urinary tract
7.7.5. Female reproductive tract
7.7.6. Through a small incisions
7.8. Market Size (US$ Mn) Forecast By Areas Type, 2022–2028
7.9. Historical Market Size (US$ Mn) Trend Analysis By End User, 2013–2021
7.9.1. Hospital
7.9.2. Ambulatory Surgical Centers
7.9.3. Specialty Clinics
7.9.4. Diagnostic Imaging Centers
7.10. Market Size (US$ Mn) Forecast By End User, 2022–2028
7.11. Market Attractiveness Analysis
7.11.1. By Country
7.11.2. By Product
7.11.3. By Areas
7.11.4. By End User
7.12. Key Market Participants – Intensity Mapping
7.13. Drivers and Restraints – Impact Analysis
8. Latin America Endoscopy Visualization Systems Market Analysis 2013–2021 and Forecast 2022–2028
8.1. Introduction
8.2. Regional Market Trends
8.3. Historical Market Size (US$ Mn) By Country, 2013–2021
8.3.1. Brazil
8.3.2. Mexico
8.3.3. Rest of Latin America
8.4. Market Size (US$ Mn) Forecast By Country, 2022–2028
8.5. Historical Market Size (US$ Mn) Trend Analysis By Product Type, 2013–2021
8.5.1. High-Range Endoscopy Visualization Systems
8.5.2. Mid-Range Endoscopy Visualization Systems
8.5.3. Low-Range Endoscopy Visualization Systems
8.6. Market Size (US$ Mn) Forecast By Product Type, 2022–2028
8.7. Historical Market Size (US$ Mn) Trend Analysis By Areas Type, 2013–2021
8.7.1. Gastrointestinal tract
8.7.2. Respiratory tract
8.7.3. Ear
8.7.4. Urinary tract
8.7.5. Female reproductive tract
8.7.6. Through a small incisions
8.8. Market Size (US$ Mn) Forecast By Areas Type, 2022–2028
8.9. Historical Market Size (US$ Mn) Trend Analysis By End User, 2013–2021
8.9.1. Hospital
8.9.2. Ambulatory Surgical Centers
8.9.3. Specialty Clinics
8.9.4. Diagnostic Imaging Centers
8.10. Market Size (US$ Mn) Forecast By End User, 2022–2028
8.11. Market Attractiveness Analysis
8.11.1. By Country
8.11.2. By Product
8.11.3. By Areas
8.11.4. By End User
8.12. Key Market Participants – Intensity Mapping
8.13. Drivers and Restraints – Impact Analysis
9. Western Europe Endoscopy Visualization Systems Market Analysis 2013–2021 and Forecast 2022–2028
9.1. Introduction
9.2. Regional Market Trends
9.3. Historical Market Size (US$ Mn) By Country, 2013–2021
9.3.1. Germany
9.3.2. France
9.3.3. U.K.
9.3.4. Spain
9.3.5. Italy
9.3.6. Rest of Western Europe
9.4. Market Size (US$ Mn) Forecast By Country, 2022–2028
9.5. Historical Market Size (US$ Mn) Trend Analysis By Product Type, 2013–2021
9.5.1. High-Range Endoscopy Visualization Systems
9.5.2. Mid-Range Endoscopy Visualization Systems
9.5.3. Low-Range Endoscopy Visualization Systems
9.6. Market Size (US$ Mn) Forecast By Product Type, 2022–2028
9.7. Historical Market Size (US$ Mn) Trend Analysis By Areas Type, 2013–2021
9.7.1. Gastrointestinal tract
9.7.2. Respiratory tract
9.7.3. Ear
9.7.4. Urinary tract
9.7.5. Female reproductive tract
9.7.6. Through a small incisions
9.8. Market Size (US$ Mn) Forecast By Areas Type, 2022–2028
9.9. Historical Market Size (US$ Mn) Trend Analysis By End User, 2013–2021
9.9.1. Hospital
9.9.2. Ambulatory Surgical Centers
9.9.3. Specialty Clinics
9.9.4. Diagnostic Imaging Centers
9.10. Market Size (US$ Mn) Forecast By End User, 2022–2028
9.11. Market Attractiveness Analysis
9.11.1. By Country
9.11.2. By Product
9.11.3. By Areas
9.11.4. By End User
9.12. Key Market Participants – Intensity Mapping
9.13. Drivers and Restraints – Impact Analysis
10. Eastern Europe Endoscopy Visualization Systems Market Analysis 2013–2021 and Forecast 2022–2028
10.1. Introduction
10.2. Regional Market Trends
10.3. Historical Market Size (US$ Mn) By Country, 2013–2021
10.3.1. Russia
10.3.2. Poland
10.3.3. Rest of Eastern Europe
10.4. Market Size (US$ Mn) Forecast By Country, 2022–2028
10.5. Historical Market Size (US$ Mn) Trend Analysis By Product Type, 2013–2021
10.5.1. High-Range Endoscopy Visualization Systems
10.5.2. Mid-Range Endoscopy Visualization Systems
10.5.3. Low-Range Endoscopy Visualization Systems
10.6. Market Size (US$ Mn) Forecast By Product Type, 2022–2028
10.7. Historical Market Size (US$ Mn) Trend Analysis By Areas Type, 2013–2021
10.7.1. Gastrointestinal tract
10.7.2. Respiratory tract
10.7.3. Ear
10.7.4. Urinary tract
10.7.5. Female reproductive tract
10.7.6. Through a small incisions
10.8. Market Size (US$ Mn) Forecast By Areas Type, 2022–2028
10.9. Historical Market Size (US$ Mn) Trend Analysis By End User, 2013–2021
10.9.1. Hospital
10.9.2. Ambulatory Surgical Centers
10.9.3. Specialty Clinics
10.9.4. Diagnostic Imaging Centers
10.10. Market Size (US$ Mn) Forecast By End User, 2022–2028
10.11. Market Attractiveness Analysis
10.11.1. By Country
10.11.2. By Product
10.11.3. By Areas
10.11.4. By End User
10.12. Key Market Participants – Intensity Mapping
10.13. Drivers and Restraints – Impact Analysis
11. Asia Pacific excluding Japan (APEJ) Endoscopy Visualization Systems Market Analysis 2013–2021 and Forecast 2022–2028
11.1. Introduction
11.2. Regional Market Trends
11.3. Historical Market Size (US$ Mn) By Country, 2013–2021
11.3.1. India
11.3.2. China
11.3.3. Australia and New Zealand
11.3.4. ASEAN
11.3.5. Rest of APEJ
11.4. Market Size (US$ Mn) Forecast By Country, 2022–2028
11.5. Historical Market Size (US$ Mn) Trend Analysis By Product Type, 2013–2021
11.5.1. High-Range Endoscopy Visualization Systems
11.5.2. Mid-Range Endoscopy Visualization Systems
11.5.3. Low-Range Endoscopy Visualization Systems
11.6. Market Size (US$ Mn) Forecast By Product Type, 2022–2028
11.7. Historical Market Size (US$ Mn) Trend Analysis By Areas Type, 2013–2021
11.7.1. Gastrointestinal tract
11.7.2. Respiratory tract
11.7.3. Ear
11.7.4. Urinary tract
11.7.5. Female reproductive tract
11.7.6. Through a small incisions
11.8. Market Size (US$ Mn) Forecast By Areas Type, 2022–2028
11.9. Historical Market Size (US$ Mn) Trend Analysis By End User, 2013–2021
11.9.1. Hospital
11.9.2. Ambulatory Surgical Centers
11.9.3. Specialty Clinics
11.9.4. Diagnostic Imaging Centers
11.10. Market Size (US$ Mn) Forecast By End User, 2022–2028
11.11. Market Attractiveness Analysis
11.11.1. By Country
11.11.2. By Product
11.11.3. By Areas
11.11.4. By End User
11.12. Market Size (US$ Mn) Forecast By End User, 2022–2028
11.13. Key Market Participants – Intensity Mapping
11.14. Drivers and Restraints – Impact Analysis
12. Japan Endoscopy Visualization Systems Market Analysis 2013–2021 and Forecast 2022–2028
12.1. Introduction
12.2. Market Trends
12.3. Historical Market Size (US$ Mn) Trend Analysis By Product Type, 2013–2021
12.3.1. High-Range Endoscopy Visualization Systems
12.3.2. Mid-Range Endoscopy Visualization Systems
12.3.3. Low-Range Endoscopy Visualization Systems
12.4. Market Size (US$ Mn) Forecast By Product Type, 2022–2028
12.5. Historical Market Size (US$ Mn) Trend Analysis By Areas Type, 2013–2021
12.5.1. Gastrointestinal tract
12.5.2. Respiratory tract
12.5.3. Ear
12.5.4. Urinary tract
12.5.5. Female reproductive tract
12.5.6. Through a small incisions
12.6. Market Size (US$ Mn) Forecast By Areas Type, 2022–2028
12.7. Historical Market Size (US$ Mn) Trend Analysis By End User, 2013–2021
12.7.1. Hospital
12.7.2. Ambulatory Surgical Centers
12.7.3. Specialty Clinics
12.7.4. Diagnostic Imaging Centers
12.8. Market Size (US$ Mn) Forecast By End User, 2022–2028
12.9. Market Attractiveness Analysis
12.9.1. By Product
12.9.2. By Areas
12.9.3. By End User
12.10. Key Market Participants – Intensity Mapping
12.11. Drivers and Restraints – Impact Analysis
13. MEA Endoscopy Visualization Systems Market Analysis 2013–2021 and Forecast 2022–2028
13.1. Introduction
13.2. Regional Market Trends
13.3. Historical Market Size (US$ Mn) By Country, 2013–2021
13.3.1. GCC Countries
13.3.2. South Africa
13.3.3. Rest of MEA
13.4. Market Size (US$ Mn) Forecast By Country, 2022–2028
13.5. Historical Market Size (US$ Mn) Trend Analysis By Product Type, 2013–2021
13.5.1. High-Range Endoscopy Visualization Systems
13.5.2. Mid-Range Endoscopy Visualization Systems
13.5.3. Low-Range Endoscopy Visualization Systems
13.6. Market Size (US$ Mn) Forecast By Product Type, 2022–2028
13.7. Historical Market Size (US$ Mn) Trend Analysis By Areas Type, 2013–2021
13.7.1. Gastrointestinal tract
13.7.2. Respiratory tract
13.7.3. Ear
13.7.4. Urinary tract
13.7.5. Female reproductive tract
13.7.6. Through a small incisions
13.8. Market Size (US$ Mn) Forecast By Areas Type, 2022–2028
13.9. Historical Market Size (US$ Mn) Trend Analysis By End User, 2013–2021
13.9.1. Hospital
13.9.2. Ambulatory Surgical Centers
13.9.3. Specialty Clinics
13.9.4. Diagnostic Imaging Centers
13.10. Market Size (US$ Mn) Forecast By End User, 2022–2028
13.11. Market Attractiveness Analysis
13.11.1. By Country
13.11.2. By Product
13.11.3. By Areas
13.11.4. By End User
13.12. Key Market Participants – Intensity Mapping
13.13. Drivers and Restraints – Impact Analysis
14. Forecast Factors: Relevance and Impact
15. Competition Analysis
15.1. Competition Dashboard
15.2. Company Deep Dive
15.2.1. Olympus Corporation
15.2.1.1. Overview
15.2.1.2. Product and Application Portfolio
15.2.1.3. Production Footprint
15.2.1.4. Sales Footprint
15.2.1.5. Channel Footprint
15.2.1.6. Strategy
15.2.1.6.1. Marketing Strategy
15.2.1.6.2. Product Strategy
15.2.1.6.3. Channel Strategy
15.2.2. KARL STORZ GmbH & Co KG
15.2.2.1. Overview
15.2.2.2. Product and Application Portfolio
15.2.2.3. Production Footprint
15.2.2.4. Sales Footprint
15.2.2.5. Channel Footprint
15.2.2.6. Strategy
15.2.2.6.1. Marketing Strategy
15.2.2.6.2. Product Strategy
15.2.2.6.3. Channel Strategy
15.2.3. Pentax Medical Company (Hoya Corporation)
15.2.3.1. Overview
15.2.3.2. Product and Application Portfolio
15.2.3.3. Production Footprint
15.2.3.4. Sales Footprint
15.2.3.5. Channel Footprint
15.2.3.6. Strategy
15.2.3.6.1. Marketing Strategy
15.2.3.6.2. Product Strategy
15.2.3.6.3. Channel Strategy
15.2.4. Stryker Corporation
15.2.4.1. Overview
15.2.4.2. Product and Application Portfolio
15.2.4.3. Production Footprint
15.2.4.4. Sales Footprint
15.2.4.5. Channel Footprint
15.2.4.6. Strategy
15.2.4.6.1. Marketing Strategy
15.2.4.6.2. Product Strategy
15.2.4.6.3. Channel Strategy
15.2.5. Fujifilm Holding Corporation
15.2.5.1. Overview
15.2.5.2. Product and Application Portfolio
15.2.5.3. Production Footprint
15.2.5.4. Sales Footprint
15.2.5.5. Channel Footprint
15.2.5.6. Strategy
15.2.5.6.1. Marketing Strategy
15.2.5.6.2. Product Strategy
15.2.5.6.3. Channel Strategy
15.2.6. CONMED Corporation
15.2.6.1. Overview
15.2.6.2. Product and Application Portfolio
15.2.6.3. Production Footprint
15.2.6.4. Sales Footprint
15.2.6.5. Channel Footprint
15.2.6.6. Strategy
15.2.6.6.1. Marketing Strategy
15.2.6.6.2. Product Strategy
15.2.6.6.3. Channel Strategy
15.2.7. Boston Scientific Corporation
15.2.7.1. Overview
15.2.7.2. Product and Application Portfolio
15.2.7.3. Production Footprint
15.2.7.4. Sales Footprint
15.2.7.5. Channel Footprint
15.2.7.6. Strategy
15.2.7.6.1. Marketing Strategy
15.2.7.6.2. Product Strategy
15.2.7.6.3. Channel Strategy
15.2.8. Smith & Nephew PLC.
15.2.8.1. Overview
15.2.8.2. Product and Application Portfolio
15.2.8.3. Production Footprint
15.2.8.4. Sales Footprint
15.2.8.5. Channel Footprint
15.2.8.6. Strategy
15.2.8.6.1. Marketing Strategy
15.2.8.6.2. Product Strategy
15.2.8.6.3. Channel Strategy
15.2.9. Richard Wolf GmbH
15.2.9.1. Overview
15.2.9.2. Product and Application Portfolio
15.2.9.3. Production Footprint
15.2.9.4. Sales Footprint
15.2.9.5. Channel Footprint
15.2.9.6. Strategy
15.2.9.6.1. Marketing Strategy
15.2.9.6.2. Product Strategy
15.2.9.6.3. Channel Strategy
15.2.10. DePuy Synthes (Johnson & Johnson Services, Inc.)
15.2.10.1. Overview
15.2.10.2. Product and Application Portfolio
15.2.10.3. Production Footprint
15.2.10.4. Sales Footprint
15.2.10.5. Channel Footprint
15.2.10.6. Strategy
15.2.10.6.1. Marketing Strategy
15.2.10.6.2. Product Strategy
15.2.10.6.3. Channel Strategy
16. Global Endoscopy Visualization Systems Market Analysis 2013–2021 and Forecast 2022–2028, By Region
16.1. Introduction / Key Findings
16.2. Historical Market Size (US$ Mn) Trend Analysis By Region, 2013–2021
16.2.1. North America
16.2.2. Western Europe
16.2.3. Eastern Europe
16.2.4. Latin America
16.2.5. Asia Pacific excluding Japan
16.2.6. Japan
16.2.7. Middle East and Africa
16.3. Market Size (US$ Mn) Forecast By Region, 2022–2028
16.4. Market Attractiveness Analysis By Region
17. Global Endoscopy Visualization Systems Market Analysis 2013–2021 and Forecast 2022–2028, By Product
17.1. Introduction
17.2. Historical Market Size (US$ Mn) Trend Analysis By Product Type, 2013–2021
17.2.1. High-Range Endoscopy Visualization Systems
17.2.2. Mid-Range Endoscopy Visualization Systems
17.2.3. Low-Range Endoscopy Visualization Systems
17.3. Market Size (US$ Mn) Forecast By Product Type, 2022–2028
17.4. Market Attractiveness Analysis By Product Type
18. Global Endoscopy Visualization Systems Market Analysis 2013–2021 and Forecast 2022–2028, By Areas
18.1. Introduction
18.2. Historical Market Size (US$ Mn) Trend Analysis By Areas Type, 2013–2021
18.2.1. Gastrointestinal tract
18.2.2. Respiratory tract
18.2.3. Ear
18.2.4. Urinary tract
18.2.5. Female reproductive tract
18.2.6. Through a small incisions
18.3. Market Size (US$ Mn) Forecast By Areas Type, 2022–2028
18.4. Market Attractiveness Analysis By Areas Type
19. Global Endoscopy Visualization Systems Market Analysis 2013–2021 and Forecast 2022–2028, By End User
19.1. Introduction
19.2. Historical Market Size (US$ Mn) Trend Analysis By End User, 2013–2021
19.2.1. Hospital
19.2.2. Ambulatory Surgical Centers
19.2.3. Specialty Clinics
19.2.4. Diagnostic Imaging Centers
19.3. Market Size (US$ Mn) Forecast By End User, 2022–2028
19.4. Market Attractiveness Analysis By End User
20. Global Market Analysis 2013–2021 and Forecast 2022–2028
20.1. Market Value Share Analysis
20.1.1. By Country
20.1.2. By Product
20.1.3. By Areas
20.1.4. By End User
20.2. Y-o-Y Growth Analysis
20.2.1. By Country
20.2.2. By Product
20.2.3. By Areas
20.2.4. By End User
20.3.Absolute $ Opportunity
21. Assumptions and Acronyms
22. Research Methodology
Explore Healthcare Insights
View Reports